Kotak Private Equity
VC Fund
Kotak Private Equity is a financial services company.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Kotak Private Equity invests in
Stages Kotak Private Equity invests in
Countries Kotak Private Equity invests in
Round sizes
Round size
- Private Equity
- $4.3M–$14M
Investment Focus
Industry
- Health Care 4 (44%)
- Life Science 2 (22%)
- Biotechnology 2 (22%)
- Fitness 1 (11%)
- Payments 1 (11%)
Stage
- Seed 2 (22%)
- Private Equity 2 (22%)
- Series A 1 (11%)
- Series B 1 (11%)
- Series F 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Monitra Healthcare
|
Monitra Healthcare is a Hyderabad based med-tech company developing solutions that capture cardiac events anytime anywhere. Our products detect cardiac arrhythmias and cardiovascular disease at real-time for pre-emptive treatments. Cardiac monitoring is widely used to identify heart disease, to monitor cardiac activity before and after surgery andother cardiac procedures, and to assess the effects of therapeutic drugs on cardiac activity. The Company’s vision is to dramatically reduce the effects of heart disease by making monitoring and pre-emptive cardiac care a seamless part of everyday life. | $1.5M / Seed / Dec 17, 2023 | |
Zaggle
|
Zaggle is an award-winning digital payments, cashback and analytics company. The company help corporates and individuals enjoy gifts and experiences across multiple channels everyday; in the form of employee rewards and recognition, channel partner incentives, employee benefits, online shopping cash back and restaurant cash back. | $30.6M / Sep 13, 2023 | |
Eyestem
|
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treatincurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety. | $6.4M / Series A / Aug 08, 2022 | |
Licious
|
Licious is a path breaking concept in the Indian Food industry; aimed at solving the perennially existing problem of finding safe, delectable, trustworthy fresh meat in India. The company builds a world-class enterprise that's bound to upgrade the way the company procures, sells, buys, and consumes meat in India. | $149.8M / Series F / Mar 14, 2022 | |
Ahammune Biosciences
|
Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. | Seed / Apr 26, 2021 | |
Healthians
|
Healthians is an online platform that provides health test home service. It is equipped with a technology-driven healthcare matrix, an army of trained full-time phlebotomists and precision-driven alliance with labs.The company is driven by a mission is to provide affordable, accurate, and reliable test results to all. Healthians was founded in2014 and is headquartered in Gurgaon, Haryana. | Series B / Nov 18, 2019 | |
Dynaspede
|
Dynaspede is a manufacture of electro-mechanical components and sub-systems for the mechatronics business sector. | $4.3M / Private Equity / Mar 01, 2008 | |
SIRO Clinpharm
|
SIRO Clinpharm is a clinical research organisation. | $14.3M / Private Equity / Mar 01, 2007 | |
|
Dynaspede
|
Dynaspede is a manufacture of electro-mechanical components and sub-systems for the mechatronics business sector. | $4.3M / Private Equity / Mar 01, 2006 |
Co-Investors
SIDBI Venture Capital
2 deals together
3i Group
1 deal together
Abakkus
1 deal together
Alkem Laboratories
1 deal together
Amansa Capital
1 deal together
Ananta Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Kotak Private Equity invest in?
Kotak Private Equity invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed and Private Equity stage. Most of the 9 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kotak Private Equity's check size?
Kotak Private Equity typically joins rounds of $4.3M–$14M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kotak Private Equity participates in.
When did Kotak Private Equity last invest?
The most recent investment recorded for Kotak Private Equity closed in Dec 2023. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
